Severe eosinophilic asthma with nasal polyposis: A phenotype for improved sinonasal and asthma outcomes with mepolizumab therapy.

Subjects

Subjects :

Double-Blind Method
Humans
Phenotype
Anti-Asthmatic Agents therapeutic use
Antibodies, Monoclonal, Humanized therapeutic use
Asthma drug therapy
Nasal Polyps drug therapy
Paranasal Sinuses drug effects
Pulmonary Eosinophilia drug therapy

Details

Language :

English

ISSN :

1097-6825

Volume :

145

Issue :

6

Database :

MEDLINE

Journal :

The Journal of allergy and clinical immunology

Publication Type :

Report

Accession number :

32084443

Full Text :

https://doi.org/10.1016/j.jaci.2020.02.002